DrugPatentWatch Database Preview
TOSYMRA Drug Profile
Which patents cover Tosymra, and when can generic versions of Tosymra launch?
Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. There are six patents protecting this drug.
This drug has forty-six patent family members in fourteen countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
Summary for TOSYMRA
| International Patents: | 46 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TOSYMRA at DailyMed |
Pharmacology for TOSYMRA
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1d Receptor Agonists Serotonin 1b Receptor Agonists |
US Patents and Regulatory Information for TOSYMRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TOSYMRA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2011006790 | Start Trial |
| Canada | 2748268 | Start Trial |
| New Zealand | 593782 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2019157099 | Start Trial |
| Russian Federation | 2011130526 | Start Trial |
| Canada | 2775404 | Start Trial |
| China | 102933198 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
